Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 222,000 | 238,400 | 141,000 | -445,005 | 138,557 |
| Depreciation Amortization | 189,000 | 170,700 | 253,600 | 218,346 | 206,726 |
| Income taxes - deferred | -19,000 | 3,500 | -6,300 | -24,688 | -5,168 |
| Accounts receivable | -108,200 | -39,100 | 120,600 | 66,172 | -82,373 |
| Other Working Capital | -87,000 | -38,200 | -17,700 | 116,297 | -90,226 |
| Other Operating Activity | 180,000 | 81,300 | -64,000 | 540,243 | 157,987 |
| Operating Cash Flow | $376,800 | $416,600 | $427,200 | $471,365 | $325,503 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,000 | -1,500 | -3,200 | 147,339 | 215,905 |
| PPE Investments | -52,400 | -63,500 | -60,700 | -22,876 | -78,833 |
| Net Acquisitions | -968,200 | N/A | N/A | -1,544,322 | N/A |
| Purchase Of Investment | 0 | N/A | -1,100 | -12,684 | -21,905 |
| Sale Of Investment | 0 | 8,200 | N/A | 13,721 | 4,189 |
| Purchase Sale Intangibles | -16,500 | -37,000 | -800 | -597 | -3,001 |
| Other Investing Activity | -16,500 | -36,600 | 700 | -597 | -3,001 |
| Investing Cash Flow | $-1,036,100 | $-93,400 | $-64,300 | $-1,419,419 | $116,355 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 67,900 | 2,600 | N/A | N/A |
| Debt Issued | 1,109,900 | N/A | N/A | 650,000 | N/A |
| Debt Repayment | -786,600 | -95,600 | -329,500 | -23,363 | -1,484 |
| Common Stock Issued | 33,400 | 8,400 | 16,200 | 8,137 | 28,424 |
| Common Stock Repurchased | -3,600 | -900 | -1,800 | N/A | -300,000 |
| Financing Cash Flow | $353,100 | $-20,200 | $-312,500 | $634,774 | $-273,060 |
| Beginning Cash Position | 507,600 | 204,600 | 154,200 | 467,451 | 298,653 |
| End Cash Position | 201,400 | 507,600 | 204,600 | 154,171 | 467,451 |
| Net Cash Flow | $-306,200 | $303,000 | $50,400 | $-313,280 | $168,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | 376,800 | 416,600 | 427,200 | 471,365 | 325,503 |
| Capital Expenditure | -55,400 | -63,500 | -75,100 | -44,431 | -78,833 |
| Free Cash Flow | 321,400 | 353,100 | 352,100 | 426,934 | 246,670 |